| Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER) F André, T Bachelot, F Commo, M Campone, M Arnedos, V Dieras, ... The lancet oncology 15 (3), 267-274, 2014 | 438 | 2014 |
| ERCC1 isoform expression and DNA repair in non–small-cell lung cancer L Friboulet, KA Olaussen, JP Pignon, FA Shepherd, MS Tsao, S Graziano, ... New England Journal of Medicine 368 (12), 1101-1110, 2013 | 428 | 2013 |
| Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors NF Delahaye, S Rusakiewicz, I Martins, C Ménard, S Roux, L Lyonnet, ... Nature medicine 17 (6), 700-707, 2011 | 393 | 2011 |
| Mutational profile of metastatic breast cancers: a retrospective analysis C Lefebvre, T Bachelot, T Filleron, M Pedrero, M Campone, JC Soria, ... PLoS medicine 13 (12), e1002201, 2016 | 371 | 2016 |
| Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors S Rusakiewicz, M Semeraro, M Sarabi, M Desbois, C Locher, R Mendez, ... Cancer research 73 (12), 3499-3510, 2013 | 333 | 2013 |
| Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer S Vignot, GM Frampton, JC Soria, R Yelensky, F Commo, C Brambilla, ... J Clin Oncol 31 (17), 2167-2172, 2013 | 182 | 2013 |
| Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy V Quidville, S Alsafadi, A Goubar, F Commo, V Scott, C Pioche-Durieu, ... Cancer research 73 (7), 2247-2258, 2013 | 160 | 2013 |
| Enhancement of mRNA in situ hybridization signal by microwave heating. M Sibony, F Commo, P Callard, JM Gasc Laboratory investigation; a journal of technical methods and pathology 73 (4 …, 1995 | 159 | 1995 |
| Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients M Semeraro, S Rusakiewicz, V Minard-Colin, NF Delahaye, D Enot, ... Science translational medicine 7 (283), 283ra55-283ra55, 2015 | 152 | 2015 |
| Prognostic impact of vitamin B6 metabolism in lung cancer L Galluzzi, I Vitale, L Senovilla, KA Olaussen, G Pinna, T Eisenberg, ... Cell reports 2 (2), 257-269, 2012 | 126 | 2012 |
| Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites C Gomez-Roca, CM Raynaud, F Penault-Llorca, O Mercier, F Commo, ... Journal of Thoracic Oncology 4 (10), 1212-1220, 2009 | 111 | 2009 |
| Expression of erythropoietin and erythropoietin receptor in non–small cell lung carcinomas K Dagnon, E Pacary, F Commo, M Antoine, M Bernaudin, JF Bernaudin, ... Clinical cancer research 11 (3), 993-999, 2005 | 111 | 2005 |
| CFTR, MDR1, and MRP1 immunolocalization in normal human nasal respiratory mucosa MA Wioland, J Fleury–Feith, P Corlieu, F Commo, G Monceaux, ... Journal of Histochemistry & Cytochemistry 48 (9), 1215-1222, 2000 | 100 | 2000 |
| MDR1-Pgp 170 expression in human bronchus E Lechapt-Zalcman, I Hurbain, R Lacave, F Commo, T Urban, M Antoine, ... European Respiratory Journal 10 (8), 1837-1843, 1997 | 97 | 1997 |
| Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study C Fouquet, M Antoine, P Tisserand, R Favis, M Wislez, F Commo, ... Clinical Cancer Research 10 (10), 3479-3489, 2004 | 88 | 2004 |
| DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer CM Raynaud, J Hernandez, FP Llorca, P Nuciforo, MC Mathieu, F Commo, ... American journal of clinical oncology 33 (4), 341-345, 2010 | 86 | 2010 |
| Molecular characteristics of ERCC1-negative versus ERCC1-positive tumors in resected NSCLC L Friboulet, D Barrios-Gonzales, F Commo, KA Olaussen, S Vagner, ... Clinical Cancer Research 17 (17), 5562-5572, 2011 | 83 | 2011 |
| Histopathological validation of the sentinel node concept in cervical cancer E Barranger, A Cortez, F Commo, O Marpeau, S Uzan, E Darai, P Callard Annals of oncology 15 (6), 870-874, 2004 | 81 | 2004 |
| Differential expression of biomarkers in men and women D Planchard, Y Loriot, A Goubar, F Commo, JC Soria Seminars in oncology 36 (6), 553-565, 2009 | 78 | 2009 |
| Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor β A Hertig, J Berrou, Y Allory, L Breton, F Commo, MAC De Beauregard, ... The FASEB journal 17 (13), 1-24, 2003 | 77 | 2003 |
